The tumor immune microenvironment of nasopharyngeal carcinoma after gemcitabine plus cisplatin treatmentJia‐Wei Lv, Jun Ma, Guan‐Qun Zhou et al.|Nature Medicine|2023Cited by 104
Medial retropharyngeal nodal region sparing radiotherapy versus standard radiotherapy in patients with nasopharyngeal carcinoma: open label, non-inferiority, multicentre, randomised, phase 3 trialYan‐Ping Mao, Jun Ma, Shunxin Wang et al.|BMJ|2023Cited by 42